BioHorizons is dedicated to developing evidence-based and scientifically proven products. From the launch of the External implant system (Maestro) in 1997, to the recent launches of Tapered Plus and Tapered 3.0, dental professionals as well as patients have confidence in our comprehensive portfolio of dental implants and biologics products.
In vitro validation
Laboratory tests were conducted to evaluate the amount of load implants can sustain both in static and fatigue. Whether evaluating the implant connection of the Maestro
11 or the implant design of the One-piece 3.0,
12 BioHorizons implants have been shown to rank at the top when compared to competitive designs.
In vivo research
To evaluate various features of the implants including thread design and implant surface, a series of pre-clinical studies were implemented with a focus on bone response. In these studies, it was shown that the BioHorizons thread design and implant surface exhibited higher bone-to-implant contact
13,14 and greater reverse torque measurements
14 than the designs typically used by other companies.
clinical evidence
To assess how BioHorizons implants can benefit patients, a number of human studies were sponsored with long term follow-up out to 10 years. Several clinical scenarios were used to determine how effective BioHorizons implants are when: immediately placed,
4 immediately loaded,
5,6,15 used in the posterior maxilla,
8 used in sinus augmentations,
9 used in poor quality bone and used in patients with compromised immune systems.
16 BioHorizons implants have been shown to have an extremely high survival rate (99.2% average),
1-10 excellent bone-to-implant contact
15 and minimal bone loss.
3,6,8,17
Comparative SEM images show the variation in tissue attachment strength on standard and Laser-Lok
abutments when a tissue flap is incised vertically and manually lifted using forceps.27
